HOMA-IR was ≥ 2.50 in 49% of cases – OR 1.86 (C.I.95% =0.42 to 0.52) respect to 34% of controls (C.I.95% =0.03 to 0.38), showing a positive trend for breast cancer patients.
← all excerpts
Homeostasis model assessment to detect insulin resistance and identify patients at high risk of breast cancer development: National Cancer Institute of Naples experience.
1
—
—